Valsts: Izraēla
Valoda: angļu
Klimata pārmaiņas: Ministry of Health
RAMIPRIL
RAFA LABORATORIES LTD
C09AA05
CAPSULES
RAMIPRIL 10 MG
PER OS
Required
RAFA LABORATORIES LTD, JERUSALEM
RAMIPRIL
RAMIPRIL
Hypertension congestive heart failure reduction of mortality in patients after MI with left ventricular dysfunction. For reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous MI unstable angina or multivessel CABG or multivessel PTCA) stroke or peripheral vascular disease. Also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : - hypertension (systolic blood pressure > 160 mmHg or diastolic pressure > 90 mmHg) - high total cholesterol (>5.2 mmol/L) - low HDL ( <0.9 mmol/L) - current smoker - known microalbuminuria - clinical evidence of previous vascular disease. Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.
2014-08-31
1 PATIENT LEAFLET ACCORDING TO THE PHARMACISTS' REGULATIONS (PREPARATIONS) – 1986 This medicine is sold with a doctor's prescription only RAMITENS 10 CAPSULES ACTIVE INGREDIENT: Each Ramitens 10 capsule contains: Ramipril 10 mg Inactive ingredients - see section 6. See also 'Important information about some of the medicine's ingredients' in section 2. READ THIS ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have any further questions, please refer to your doctor or pharmacist. This medicine has been prescribed for treatment for you. Do not pass it on to others. It may harm them, even if you think their medical condition is similar to yours. 1. WHAT IS THE MEDICINE INTENDED FOR? The medicine is used to treat hypertension, to reduce the risk of having a heart attack or stroke, to reduce the risk or to delay the worsening of kidney problems (in diabetic or nondiabetic patients), to treat heart failure, as treatment following a heart attack complicated with heart failure. THERAPEUTIC GROUP: Antihypertensive, belongs to the ACE inhibitors group. 2. BEFORE USING THE MEDICINE DO NOT USE THE MEDICINE IF: − You are sensitive (allergic) to the active ingredient ramipril or to any other preparation from the ACE inhibitors group, or to any of the other ingredients the medicine contains (see section 6). Signs of an allergic reaction may include: rash, swallowing or breathing difficulties, swelling of the lips, face, throat or tongue. − You suffered in the past from a serious allergic reaction called angioedema, whose signs include: itching, hives (urticaria), red marks on the hands, feet and throat, swelling of the throat and tongue, swelling around the eyes and lips, breathing and swallowing difficulties. − You have taken or are currently taking sacubitril/valsartan, a medicine used to treat a type of chronic heart failure in adults. − You are undergoing dialysis or any other type of blood filtration. Depending on the type of machine in use, Izlasiet visu dokumentu